22.8 C
New York
Friday, July 11, 2025

Tag: division

Miho Sato Wins AXA Art Prize UK 2025

LONDON, July 11, 2025 /PRNewswire/ -- AXA XL is pleased to announce Miho Sato as the winner of the AXA Art Prize UK 2025. Ms....

Dickinson Wright Files Lawsuit Against ‘John Doe’ ‘Naked’ Short-Sellers of Datavault AI Common Stock

WASHINGTON, D.C., July 10, 2025 (GLOBE NEWSWIRE) -- via IBN – On Thursday, July 10, 2025, Dickinson Wright filed a lawsuit on behalf of the law firm’s client, Datavault AI, Inc. (Nasdaq: DVLT), (Datavault AI), alleging securities fraud (stock manipulation), defamation and intentional tort against “John Doe” “naked” short sellers of Datavault AI common stock on the Nasdaq Stock Market. The Complaint alleges that the short sellers engaged in the unlawful practice of “naked short selling” and other manipulative devices – including marking the close, painting the tape, spoofing and layering. The Complaint further alleges that the “John Does” for themselves or acting in concert with the “naked” short sellers also published materially false and misleading and defamatory information on internet chat room “Stocktwits” and on LinkedIn. The lawsuit, filed in federal court in Chicago, seeks unspecified compensatory and special damages and other relief.

NKGen Biotech Administers First Dose of Troculeucel to Alzheimer’s Patient Who Continued to Decline Cognitively While on Prior Amyloid-Targeting Therapy

SANTA ANA, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell therapeutics, today announced the administration of the first dose of troculeucel, an expanded autologous NK cell therapy, under a single compassionate use, Investigational New Drug (“IND”) authorization cleared by the U.S. Food and Drug Administration (“FDA”), to a patient with mild-stage Alzheimer’s disease who exhibited continued cognitive decline despite ongoing treatment with lecanemab, an amyloid targeting therapy. This exploratory work is being conducted in collaboration with Anita Fletcher, M.D., a board-certified neurologist with specialized training in neuroimmunology, who also serves as Director of Neuroscience Clinical Research at AdventHealth Neuroscience Institute in Orlando, Florida.

Chinola Fresh Fruit Liqueurs Expands Distribution with Southern Glazer’s Wine & Spirits Travel Retail Sales & Export Division

A strategic agreement poised to accelerate Chinola's global footprint across key export and travel retail markets. NEW YORK, July 10, 2025 /PRNewswire/ -- Chinola Fresh...

Toll Brothers Honored at the New Jersey Builders Association and Shore Builders Association Awards Ceremonies

Company’s New Jersey Division wins over a dozen awards, including Townhome Community of the Year for Middletown Walk
Company’s New Jersey Division wins over a dozen awards, including Townhome Community of the Year for Middletown Walk

NextNRG Reports Preliminary June 2025 Revenue Growth of 231% Year-Over-Year

NextNRG Reports Preliminary June 2025 Revenue Growth of 231% Year-Over-Year

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDivision